SCHEMBL10567559

SCHEMBL10567559

COc1ccc(-c2cc(=S)[nH]c(=O)[nH]2)cc1OC

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 5/20 0.54
▸ MAPT P10636 5/20 0.54
▸ THRB P10828 1/20 0.54
▸ NPC1 O15118 1/20 0.47
▸ PDE4A P27815 3/20 0.47
▸ PDE4B Q07343 3/20 0.47
▸ PDE4C Q08493 3/20 0.47
▸ PDE4D Q08499 3/20 0.47
▸ ALDH1A1 P00352 7/20 0.46
▸ GAA P10253 5/20 0.44
▸ MPI P34949 1/20 0.44
▸ GFER P55789 1/20 0.44
▸ APOBEC3G Q9HC16 1/20 0.44
▸ TDP1 Q9NUW8 1/20 0.44
▸ KMT2A Q03164 5/20 0.44
▸ MEN1 O00255 3/20 0.44
▸ SMN1; SMN2 Q16637 2/20 0.43
▸ HSD17B10 Q99714 1/20 0.42
▸ PDE3B Q13370 1/20 0.41
▸ PDE3A Q14432 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10569385 0.84 KDM4E (0.66) KDM4EMAPTTHRBNPC1PDE4A
SCHEMBL10653538 0.84 CCNB2 (0.48) KDM4EMAPTPDE4BALDH1A1GAA
SCHEMBL10565006 0.75 ALDH1A1 (0.55) KDM4EMAPTTHRBNPC1ALDH1A1
SCHEMBL10565244 0.73 MAPT (0.47) KDM4EMAPTTHRBPDE4APDE4B
SCHEMBL10565240 0.73 MAPT (0.47) KDM4EMAPTTHRBPDE4APDE4B
SCHEMBL11097371 0.72 CA2 (0.53) KDM4EALDH1A1GAAMPIAPOBEC3G
SCHEMBL10568592 0.72 KDM4E (0.46) KDM4EMAPTTHRBNPC1PDE4A
SCHEMBL3343223 0.71 NPC1 (0.49) KDM4EMAPTTHRBNPC1PDE4A
SCHEMBL10339766 0.71 KDM4E (0.57) KDM4EMAPTTHRBNPC1PDE4A
SCHEMBL10652922 0.70 KDM4E (0.59) KDM4EMAPTTHRBPDE4APDE4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4824851-A Pyrimidones as cardiotonic, anti hypertensive, cerebrovascular vasodilator and anti-platelet agents FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1989-04-25 — — US disclosed
EP-0123402-B1 PYRIMIDINE DERIVATIVES, PREPARATION THEREOF AND USE THEREOF FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1988-09-07 — — EP disclosed
US-4746664-A Substituted-3,4-dihydro-4-(2,4,6-trimethoxyphenylimino)-2(1H)-pyrimidones useful as cardiotonic, antihypertensive, cerebrovascular vasodilator and anti-platelet agent FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1988-05-24 — — US disclosed
US-4612376-A Substituted-3,4-dihydro-4-(2,4,6-trimethoxyphenylimino)-2(1H)-pyrimidones useful as cardiotonic, antihypertensive, cerebrovascular vasodilator and anti-platelet agent FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1986-09-16 — — US disclosed
EP-0123402-A2 Pyrimidine derivatives, preparation thereof and use thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1984-10-31 — — EP disclosed
Send feedback